Old Web
English
Sign In
Acemap
>
authorDetail
>
Dawn K. Slifka
Dawn K. Slifka
Immunology
Immunogenicity
Biology
Vaccine efficacy
Immunity
2
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults
2019
Vaccine
Christopher W. Woods
Ana M. Sanchez
Geeta K. Swamy
Micah T. McClain
Lynn Harrington
D. Freeman
Elizabeth A. Poore
Dawn K. Slifka
Danae E. Poer DeRaad
Ian J. Amanna
Mark K. Slifka
Shu Cai
Venus Shahamatdar
Michael R. Wierzbicki
Cyrille Amegashie
Emmanuel B. Walter
Show All
Source
Cite
Save
Citations (13)
Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine
2017
Vaccine
Elizabeth A. Poore
Dawn K. Slifka
Hans Peter Raué
Archana Thomas
Erika Hammarlund
Benjamin K. Quintel
Lindsay L. Torrey
Ariel M. Slifka
Justin M. Richner
Melissa E. Dubois
Lawrence P. Johnson
Michael S. Diamond
Mark K. Slifka
Ian J. Amanna
Show All
Source
Cite
Save
Citations (12)
1